Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

13.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

92
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
92
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

943
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
943
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

794
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
794
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

682
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
682

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DMAPLM: A multimodal pretrained framework for computational drug repositioning.

PLoS computational biology·2026
Same author

DWPL-GCNMF: Structure-Aware Dynamic Weighted Pseudo-Label Learning for Adverse Drug Reaction Prediction.

Journal of chemical information and modeling·2026
Same author

Ensemble learning based on matrix completion improves microbe-disease association prediction.

Briefings in bioinformatics·2025
Same author

Predicting disease-associated microbes based on similarity fusion and deep learning.

Briefings in bioinformatics·2024
Same author

Predicting circRNA-drug sensitivity associations by learning multimodal networks using graph auto-encoders and attention mechanism.

Briefings in bioinformatics·2023
Same author

Predicting miRNA-disease associations based on lncRNA-miRNA interactions and graph convolution networks.

Briefings in bioinformatics·2022
Same journal

Correction to "Mathematical Modelling of COVID-19 Transmission in Kenya: A Model with Reinfection Transmission Mechanism".

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Empirical Analysis of the Nursing Effect of Intelligent Medical Internet of Things in Postoperative Osteoarthritis.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Evaluation and Analysis of the Intervention Effect of Systematic Parent Training Based on Computational Intelligence on Child Autism.

Computational and mathematical methods in medicine·2024
Same journal

RETRACTION: Humanistic Spirit Training of Medical Students Based on Multisource Medical Data Fusion.

Computational and mathematical methods in medicine·2024
See all related articles

Related Experiment Video

Updated: Apr 12, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

Network-based inference methods for drug repositioning.

Hailin Chen1, Heng Zhang2, Zuping Zhang3

  • 1School of Software, East China Jiaotong University, Nanchang 330013, China.

Computational and Mathematical Methods in Medicine
|May 14, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces novel computational methods, ProbS and HeatS, to predict drug-disease associations using network topology. These methods offer reliable predictions, accelerating drug repositioning and identifying new therapeutic indications.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.7K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

Related Experiment Videos

Last Updated: Apr 12, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.7K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

Area of Science:

  • Computational biology
  • Pharmacology
  • Network science

Background:

  • Drug repositioning accelerates pharmaceutical development but relies on potentially incomplete or erroneous biological information.
  • Existing computational methods for inferring drug-disease associations often depend on prior biological data.

Purpose of the Study:

  • To develop novel inference methods for predicting direct drug-disease associations.
  • To leverage network topology measures for association inference, reducing reliance on external biological data.
  • To facilitate drug repositioning by identifying potential new indications for existing drugs.

Main Methods:

  • Introduced two inference methods: Probabilistic Similarity (ProbS) and Heat Kernel Similarity (HeatS).
  • Utilized bipartite network topology to prioritize potential drug-disease associations.
  • Evaluated prediction performance using Area Under the Curve (AUC) metrics.

Main Results:

  • Both ProbS and HeatS demonstrated reliable prediction performance with AUC values of 0.9192 and 0.9079, respectively.
  • Case studies confirmed several predicted drug-disease associations against the Comparative Toxicogenomics Database (CTD).

Conclusions:

  • The developed methods effectively predict drug-disease associations based solely on network topology.
  • These findings support accelerated drug repositioning and suggest new drug indications for further investigation.